Publication
Article
Pharmacy Times
A woman?s relative risk of invasive cervical cancer doubles if she is screened at 2- or 3-year intervals after her last negative cervical smear, rather than at 1-year intervals, according to a case-control study published recently in Obstetrics and Gynecology. No significant difference was found between a 2- or a 3-year screening interval. Although a woman?s absolute risk for developing cervical cancer remains low, the researchers noted that these findings are important for policymakers to consider when evaluating the costs and impact of a decrease in screening frequency. The findings are based on data from 1466 women in the Kaiser Permanente health maintenance organization in northern California.
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.